Thyrocare Technologies Limited (BOM: 539871)
India
· Delayed Price · Currency is INR | Market Cap | 51.70B |
| Revenue (ttm) | 6.23B |
| Net Income (ttm) | 839.60M |
| Shares Out | 52.95M |
| EPS (ttm) | 15.76 |
| PE Ratio | 61.96 |
| Forward PE | 45.84 |
| Dividend | 18.00 (1.84%) |
| Ex-Dividend Date | Aug 16, 2024 |
| Volume | 14,566 |
| Open | 966.95 |
| Previous Close | 947.85 |
| Day's Range | 963.15 - 1,000.80 |
| 52-Week Range | 532.95 - 1,002.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 23, 2024 |
About Thyrocare Technologies
Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others. The company conducts various medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, and various infectious diseases. Its profiles of tests include profiles of tests adm... [Read more]
Financial Performance
In 2023, Thyrocare Technologies's revenue was 5.72 billion, an increase of 8.58% compared to the previous year's 5.27 billion. Earnings were 707.60 million, an increase of 9.72%.
Financial StatementsNews
Thyrocare completes acquisition of Vimta Labs’ Diagnostic business
Thyrocare Technologies Limited has successfully completed the acquisition of the diagnostic and pathological services business of Vimta Labs Limited. The acquisition was finalized on October 11, 2024,...